Christopher John Morl, Chief Business Officer at Deciphera Pharmaceuticals, Inc. (DCPH), sold 30,068 shares at $65.40 ($2.0M) on 2020-01-16, disclosed to the SEC on 2020-01-17.
Open-market sale of $2.0M DCPH by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.23 | 12,023 | $784K | 40.0% |
| 2 | $65.23 | 12,023 | $784K | 40.0% |
| 3 | $65.40 | 3,011 | $197K | 10.0% |
| 4 | $65.40 | 3,011 | $197K | 10.0% |
| Total | $65.26 avg | 30,068 | $2.0M | 100% |
| Filing → |
| DCPH | SELL | 2019-12-13 | $902K | — | Filing → |
| DCPH | SELL | 2019-12-11 | $827K | — | Filing → |
| DCPH | SELL | 2019-12-05 | $752K | — | Filing → |